| Name | 2-(4-methyl-1-piperazinyl)ethanamine |
|---|---|
| Synonyms |
1-(N-Aminoethyl)-4-methyl piperazine
2-(4-Methyl-1-piperazinyl)ethanamine EINECS 213-296-3 MFCD03701701 1-Piperazineethanamine, 4-methyl- 1-Methyl-4-(2-aminoethyl)piperazine 4-methyl-1-piperazineethanamine 2-(4-methylpiperazin-1-yl)ethanamine 1-Piperazineethanamine,4-methyl 2-(4-methyl-piperazin-1-yl)-ethylamine |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 215.4±8.0 °C at 760 mmHg |
| Molecular Formula | C7H17N3 |
| Molecular Weight | 143.230 |
| Flash Point | 83.3±13.2 °C |
| Exact Mass | 143.142242 |
| PSA | 32.50000 |
| LogP | -1.29 |
| Vapour Pressure | 0.1±0.4 mmHg at 25°C |
| Index of Refraction | 1.488 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi: Irritant; |
|---|---|
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36/37/39 |
| RIDADR | 2735.0 |
| HS Code | 2933599090 |
|
~10%
934-98-5 |
| Literature: NEUROPORE THERAPIES, INC.; WRASIDLO, Wolfgang Patent: WO2013/148365 A1, 2013 ; Location in patent: Paragraph 0086 ; |
|
~%
934-98-5 |
| Literature: US2004/192698 A1, ; Page/Page column 13 ; |
|
~%
934-98-5 |
| Literature: WO2005/97746 A2, ; Page/Page column 124-125 ; |
|
~%
934-98-5 |
| Literature: Journal of Medicinal Chemistry, , vol. 42, # 15 p. 2870 - 2880 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |